A Hydralazine hydrochloride, Apresoline CEP of the European Pharmacopoeia monograph is often referred to as a Hydralazine hydrochloride, Apresoline Certificate of Suitability (COS). The purpose of a Hydralazine hydrochloride, Apresoline CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Hydralazine hydrochloride, Apresoline EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Hydralazine hydrochloride, Apresoline to their clients by showing that a Hydralazine hydrochloride, Apresoline CEP has been issued for it. The manufacturer submits a Hydralazine hydrochloride, Apresoline CEP (COS) as part of the market authorization procedure, and it takes on the role of a Hydralazine hydrochloride, Apresoline CEP holder for the record. Additionally, the data presented in the Hydralazine hydrochloride, Apresoline CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Hydralazine hydrochloride, Apresoline DMF.
A Hydralazine hydrochloride, Apresoline CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Hydralazine hydrochloride, Apresoline CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Hydralazine hydrochloride, Apresoline suppliers with CEP (COS) on PharmaCompass.